Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572559 · ClinicalTrials.gov registry record · Phase 4
Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus
A Phase 4 study of Pneumonia, Ventilator-Associated, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 149
- Enrollment target
- 20
- Study locations
NCT00572559: Completed Phase 4 study of Pneumonia, Ventilator-Associated, sponsored by Pfizer.
NCT00572559 is a Phase 4 study of Pneumonia, Ventilator-Associated that has completed, run by Pfizer. The registered enrollment target is 149 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (71% lower). The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00572559, a Phase 4 study of Pneumonia, Ventilator-Associated, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 149 participants
- Enrollment target
- 20
- Study locations
Study Summary
Ventilator-associated pneumonia (VAP) is a commonplace complication of intensive care patients ventilated for longer than 48 hours. Methicillin-resistant Staphylococcus aureus (MRSA) is the cause of late onset VAP in up to about 30% of cases in US hospitals. Ineffective treatment of MRSA VAP clearly leads to prolonged mechanical ventilation and is probably associated with higher mortality. The purpose of this protocol is to directly compare linezolid and vancomycin specifically for MRSA VAP.
Conditions Studied
Interventions
- DRUG Vancomycin
- DRUG Linezolid
Study Locations (20)
California
- Pfizer Investigational Site - Palm Springs
- Pfizer Investigational Site - Rancho Mirage
- Pfizer Investigational Site - Redlands
- Pfizer Investigational Site - Sacramento
- Pfizer Investigational Site - Sacramento
Georgia
- Pfizer Investigational Site - Augusta
- Pfizer Investigational Site - Decatur
- Pfizer Investigational Site - North East Atlanta
- Pfizer Investigational Site - North East Atlanta
- Pfizer Investigational Site - North East Atlanta
Illinois
- Pfizer Investigational Site - Chicago
- Pfizer Investigational Site - Peoria
- Pfizer Investigational Site - Peoria
- Pfizer Investigational Site - Peoria
Connecticut
- Pfizer Investigational Site - Norwalk
- Pfizer Investigational Site - Waterbury
- Pfizer Investigational Site - Waterbury
Arizona
- Pfizer Investigational Site - Phoenix
- Pfizer Investigational Site - Phoenix
Hawaii
- Pfizer Investigational Site - ‘Ewa Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2002-11 |
| Est. Completion | 2005-01 |
| Phase | Phase 4 |
What the finished NCT00572559 record still lists
NCT00572559 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Pneumonia, Ventilator-Associated appearing as the primary indexed condition, and to 2 interventions - of which Vancomycin is the first listed.
NCT00572559 names 20 study sites across 6 states, led by California, Georgia, Illinois.
Frequently Asked Questions
What is clinical trial NCT00572559 about?
NCT00572559 is a clinical study titled "Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus". Ventilator-associated pneumonia (VAP) is a commonplace complication of intensive care patients ventilated for longer than 48 hours. Methicillin-resistant Staphylococcus aureus (MRSA) is the cause of late onset VAP in up to about 30% of cases in US hospitals. Ineffective treatment of MRSA VAP clearly...
What is the current status of trial NCT00572559?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 149 participants. The study started on 2002-11. Estimated completion is 2005-01.
What conditions does trial NCT00572559 study?
This clinical trial studies the following conditions: Pneumonia, Ventilator-Associated.
What interventions are being tested in trial NCT00572559?
The interventions under investigation include: Vancomycin (DRUG), Linezolid (DRUG).
Who is sponsoring clinical trial NCT00572559?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00572559 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Georgia, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia, Ventilator-Associated
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00572559's enrollment target sits among peer trials
149 565th of 2000 higher than 1,435 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04188535 · 149 participants · NA
Serial MRI Scans During Radiation Therapy
- NCT05828511 · 149 participants · Phase 1
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia